Literature DB >> 18192967

Distribution of human papillomavirus genotypes in invasive squamous carcinoma of the vulva.

Bobbie C Sutton1, Richard A Allen, William E Moore, S Terence Dunn.   

Abstract

Many studies have established a critical role for human papillomavirus (HPV) in the development of anogenital squamous neoplasia. In this report, we show the distribution of 37 high- and low-risk HPV types in 116 cases of invasive squamous vulvar carcinoma. Sections from paraffin-embedded tissue blocks were dissected as necessary to select areas of invasive carcinoma. Clinical and pathologic variables were analyzed using t-tests, univariate odds ratios and logistic regression analysis. Seventy percent of cases were HPV-positive, with an average patient age of 65 years (n=81). HPV-negative cases (n=35) had a higher average age (70 years), but these populations were not statistically different (t=1.65, P=0.10). HPV16 was most common (n=65). Other HPV types were less frequent (HPV33, n=12; HPV45, n=4; HPV52 and 6, each n=3; HPV18, 53 and 62, each n=2). Additional HPV types were identified only once. Multiple infections typically included HPV16 (12/14 cases). Tumors showing low-risk HPV (11 cases) and low-risk HPV only (three cases) were uncommon. Regional node metastasis was documented in 29 of 116 tumors, and 8/9 HPV-positive nodes contained HPV types identical to the primary tumor. Of tumor types, warty carcinoma was most strongly associated with high-risk HPV (odds ratio 4.34, 95% confidence interval 1.32-18.45), particularly high-risk HPVs other than type 16 (odds ratio 9.04, 95% confidence interval 1.60-54.00). Tumors associated with any HPV type (odds ratio 0.40, 95% confidence interval 0.14-1.17), any high-risk type (odds ratio 0.36, 95% confidence interval 0.12-1.08), or type 16 alone (odds ratio 0.34, 95% confidence interval 0.11-1.12) were less likely to metastasize than HPV-negative tumors. Correcting for possible confounding variables, such as patient age and tumor histology, linear logistic regression analysis confirmed this association (high-risk HPV odds ratio 0.28, 95% confidence interval 0.09-0.89).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18192967     DOI: 10.1038/modpathol.3801010

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  12 in total

1.  Prevalence of human papillomavirus types in invasive vulvar cancers and vulvar intraepithelial neoplasia 3 in the United States before vaccine introduction.

Authors:  Julia W Gargano; Edward J Wilkinson; Elizabeth R Unger; Martin Steinau; Meg Watson; Youjie Huang; Glenn Copeland; Wendy Cozen; Marc T Goodman; Claudia Hopenhayn; Charles F Lynch; Brenda Y Hernandez; Edward S Peters; Maria Sibug Saber; Christopher W Lyu; Lauren A Sands; Mona Saraiya
Journal:  J Low Genit Tract Dis       Date:  2012-10       Impact factor: 1.925

2.  Tumor proteomics by multivariate analysis on individual pathway data for characterization of vulvar cancer phenotypes.

Authors:  Annsofi Sandberg; Gunnel Lindell; Brita Nordström Källström; Rui Mamede Branca; Kristina Gemzell Danielsson; Mats Dahlberg; Barbro Larson; Jenny Forshed; Janne Lehtiö
Journal:  Mol Cell Proteomics       Date:  2012-04-12       Impact factor: 5.911

3.  Human papillomavirus-related gynecologic neoplasms: screening and prevention.

Authors:  Whitfield B Growdon; Marcela Del Carmen
Journal:  Rev Obstet Gynecol       Date:  2008

Review 4.  The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections.

Authors:  Maciej Lazarczyk; Patricia Cassonnet; Christian Pons; Yves Jacob; Michel Favre
Journal:  Microbiol Mol Biol Rev       Date:  2009-06       Impact factor: 11.056

5.  Condyloma-like squamous cell carcinoma of the vulva: report of two midline cases.

Authors:  Shyam B Verma; Uwe Wollina
Journal:  Clin Cosmet Investig Dermatol       Date:  2012-09-10

6.  Implication of human papillomavirus-66 in vulvar carcinoma: a case report.

Authors:  Ioannis C Kotsopoulos; Georgios P Tampakoudis; Dimitrios G Evaggelinos; Anastasia I Nikolaidou; Panagiota A Fytili; Vasilios C Kartsiounis; Domniki K Gerasimidou
Journal:  J Med Case Rep       Date:  2011-06-25

7.  Human papillomavirus genotyping and e6/e7 mRNA expression in greek women with intraepithelial neoplasia and squamous cell carcinoma of the vagina and vulva.

Authors:  Elpida Tsimplaki; Elena Argyri; Lina Michala; Maria Kouvousi; Aikaterini Apostolaki; George Magiakos; Issidora Papassideri; Efstathia Panotopoulou
Journal:  J Oncol       Date:  2011-12-05       Impact factor: 4.375

8.  The economic burden of human papillomavirus-related precancers and cancers in Sweden.

Authors:  Ellinor Östensson; Maria Silfverschiöld; Lennart Greiff; Christine Asciutto; Johan Wennerberg; Marie-Louise Lydrup; Ulf Håkansson; Pär Sparén; Christer Borgfeldt
Journal:  PLoS One       Date:  2017-06-26       Impact factor: 3.240

9.  HPV16 viral characteristics in primary, recurrent and metastatic vulvar carcinoma.

Authors:  Gabriella Lillsunde Larsson; Malin Kaliff; Bengt Sorbe; Gisela Helenius; Mats G Karlsson
Journal:  Papillomavirus Res       Date:  2018-11-02

10.  Human papillomavirus types in non-cervical high-grade intraepithelial neoplasias and invasive carcinomas from San Luis Potosí, Mexico: a retrospective cross-sectional study.

Authors:  Claudia Magaña-León; Cuauhtémoc Oros; Rubén López-Revilla
Journal:  Infect Agent Cancer       Date:  2015-09-28       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.